Gender-related difference in ST-elevation myocardial infarction treated with primary angioplasty: A single-centre 6-year registry

European Journal of Preventive Cardiology

Volumn 19, Issue 2, 2012, Pages 233-240

  Valente, Serafina ^a   Lazzeri, Chiara ^a   Chiostri, Marco ^a   Giglioli, Cristina ^a   Zucchini, Mery ^a   Grossi, Francesco ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Female gender; major bleeding; metabolic and inflammatory responses; mortality; PCI; ST elevation myocardial infarction

Indexed keywords

FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLEEDING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY CARE UNIT; DIABETES MELLITUS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGIC DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 84861234869     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/1741826711400511     Document Type: Article

References (23)

1. Sjauw KD, Stegenga NK, Engström AE, van der Schaaf RJ, Vis MM, Macleod A, et al. The influence of gender on short- and long-term outcome after primary PCI and delivered medical care for ST-segment elevation myocardial infarction. EuroIntervention. 2010 ; 5 (7). 780-787
2. Malacrida R, Genoni M, Maggioni AP, Spataro V, Parish S, Palmer A, et al. A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N Engl J Med. 1998 ; 338 (1). 8-14 (Pubitemid 28040169)
3. Griffith D, Hamilton K, Norrie J, Isles C. Early and late mortality after myocardial infarction in men and women: prospective observational study. Heart. 2005 ; 91: 305-307 (Pubitemid 40299207)
4. Jneid H, Fonarow GC, Cannon CP, Hernandez AF, Palacios IF, Maree AO, et al. Sex differences in medical care and early death after acute myocardial infarction. Circulation. 2008 ; 118 (25). 2803-2810
5. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009 ; 54 (23). 2205-2241
6. Valente S, Lazzeri C, Chiostri M, Giglioli C, Sori A, Tigli S, et al. NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol. 2009 ; 132 (1). 84-89
7. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. In hospital peak glycemia and prognosis in STEMI patients without previously known diabetes. Eur J Card Prev Rehab. 2010 ; 17 (4). 419-423
8. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987 ; 76: 142-154 (Pubitemid 17093202)
9. Bufe A, Wolfertz J, Dinh W, Bansemir L, Koehler T, Haltern G, et al. Gender-based differences in long-term outcome after ST-elevation myocardial infarction in patients treated with percutaneous coronary intervention. J Womens Health (Larchmt). 2010 ; 19 (3). 471-475
10. Lansky AJ, Pietras C, Costa RA, Tsuchiya Y, Brodie BR, Cox DA, et al. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation. 2005 ; 111 (13). 1611-1618 (Pubitemid 40525160)
11. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004 ; 109 (5). 672-693 (Pubitemid 38198877)
12. De Luca G, Suryapranata H, Dambrink JH, Ottervanger JP, van't Hof AW, Zijlstra F, et al. Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle myocardial infarction study. Am Heart J. 2004 ; 148 (5). 852-856
13. Vacek JL, Rosamond TL, Kramer PH, Crouse LJ, Porter CB, Robuck OW, et al. Sex-related differences in patients undergoing direct angioplasty for acute myocardial infarction. Am Heart J. 1993 ; 126 (3 Pt 1). 521-525 (Pubitemid 23274281)
14. De Luca G, Gibson CM, Gyöngyösi M, Zeymer U, Dudek D, Arntz HR, et al. Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. J Thromb Thrombolysis. 2010 ; 30 (3). 342-346
15. Park JS, Kim YJ, Shin DG, Jeong MH, Ahn YK, Chung WS, et al. Gender differences in clinical features and in-hospital outcomes in ST-segment elevation acute myocardial infarction: from the Korean Acute Myocardial Infarction Registry (KAMIR) study. Clin Cardiol. 2010 ; 33 (8). E1 - E6
16. Zhang Q, Qiu JP, Zhang RY, Li YG, He B, Jin HG, et al. Absence of gender disparity in short-term clinical outcomes in patients with acute ST-segment elevation myocardial infarction undergoing sirolimus-eluting stent based primary coronary intervention: a report from Shanghai Acute Coronary Event (SACE) Registry. Chin Med J (Engl). 2010 ; 123 (7). 782-788
17. Feit F, Voeltz MD, Attubato MJ, Lincoff MA, Chew DP, Bittl JA, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial. Am J Cardiol. 2007 ; 100: 1364-1369 (Pubitemid 47576015)
18. Moukian SV. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Am J Cardiol. 2009 ; 104 (suppl). 9C - 15C
19. Dotevall A, Hasdai D, Wallentin L, Battler A, Rosengren A. Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS. Diabet Med. 2005 ; 22 (11). 1542-1550 (Pubitemid 41641162)
20. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol. 2009 ; 54 (17). 1561-1575
21. Wong ND, Pio J, Valencia R, Thakal G. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol. 2001 ; 4 (3). 109-114 (Pubitemid 32613801)
22. Bessant R. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology. 2004 ; 43: 924-929 (Pubitemid 38996970)
23. Prather AA, Carroll JE, Fury JM, McDade KK, Ross D, Marsland AL. Gender differences in stimulated cytokine production following acute psychological stress. Brain Behav Immun. 2009 ; 23 (5). 622-628